Julie Cervesi

Julie Cervesi has a diverse work experience in the biotechnology and healthcare industries. Julie is currently the Head of Business Development at AUROBAC THERAPEUTICS since 2023. Prior to that, they worked at Da Volterra as the Head of Business Development, Intelligence and Public Funding from 2018 to 2022, where they were responsible for strategic partnerships and evaluating licensing opportunities. Julie also worked as a Project Manager in the same company from 2018 to 2020. Before that, they gained experience as a Bioentrepreneur at COGITh in 2018. Julie has also held various intern positions at Acticor Biotech, PEP-Therapy, Hôpital Sainte-Anne, BIOMODEX, Novartis, and the Department of Toxicology at the University of Salamanca. This diverse experience showcases their strong background in research, development, and strategic planning in the biotechnology field.

Julie Cervesi's education history includes obtaining a Doctor of Pharmacy (Pharm.D.) degree in Pharmaceutical Biotechnologies and Advanced Therapies from Paris-Sud University (Paris XI) in 2017, as well as a Master's degree in Bioentrepreneurship from Université Paris Cité in 2018. Julie also completed a Master of Science - MSc in Bioentrepreneurship from HEC Paris, École Polytechnique, and an ERASMUS program at Uppsala University. Julie holds additional certifications such as "Startup Valuation Methods" from Coursera and "AFGSU, Attestation de formation aux gestes et soins d’urgence de niveau 2" from the Ministre des Affaires sociales, de la Santé et des Droits des femmes. Julie also has certifications in TOEIC, CSP, and Certificat Informatique et Internet de niveau 1 (c2i), and has a driver's license (Permis B).